Genetic Susceptibility to Severe Infections

计划入组 2,000 人 · 首次发布于 2023 年 10 月 26 日

Virulence of Staphylococcus Lugdunensis in Severe Infections

计划入组 82 人 · 首次发布于 2014 年 1 月 3 日

Mechanisms of Acute Kidney Injury in Severe Infections

计划入组 15 人 · 首次发布于 2024 年 4 月 18 日

SMNH compounds (oral, norovirus infection) (Spring Bank Pharmaceuticals)

immunotherapy (nosocomial infections)

Nipah infections(Fabentech)

NATIONAL INSTITUTE OF DISEASES OF THE CHEST AND HOSPITAL

Bangladesh

VIGONVITA-B

Spero Therapeutics

United States

Pralsetinib Linked to Increased Risk of Severe Infections in NSCLC Patients

Engineered Macrophages Target Severe Bacterial Infections Without Genetic Modification

Cumberland's Vibativ Antibiotic Secures Chinese NMPA Approval for Severe Bacterial Infections